2014, Número 3-4
Neurofibromatosis 1 prevalence in children aged 9–11 years, Pinar del Río province, Cuba
Idioma: Ingles.
Referencias bibliográficas: 22
Paginas: 22-26
Archivo PDF: 132.98 Kb.
RESUMEN
Sin resumen.REFERENCIAS (EN ESTE ARTÍCULO)
Espósito M, Marotta R, Roccella M, Gallai B, Parisi L, Lavano SM, et al. Pediatric neurofibromatosis 1 and parental stress: a multicenter study. Neuropsychiatr Dis Treat. [Internet]. 2014 Jan 22 [cited 2014 Jan 6];10:141–6. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904813/pdf/ndt-10-141.pdf
Hsueh YP. From neurodevelopment to neurodegeneration: the interaction of neurofibromin and valosin-containing protein/p97 in regulation of dendritic spine formation. J Biomed Sci [Internet]. 2012 Mar 26 [cited 2014 Jan 6];19:3. Available from: http://www.jbiomedsci.com/content/pdf/1423-0127-19-33.pdf
Jiménez PE, López F, Portilla JC, Romero RM, Fermín JA, Casado I. Manifestaciones clínicas y neurorradiológicas en los adultos con neurofibromatosis tipo 1. Rev Neurol [Internet]. 2013 Jul–Aug [cited 2014 Jan 6];28(6):361–5. Available from: http://ac.els-cdn.com/S2173580813001028/1-s2.0-S2173580813001028-main.pdf?_tid=16b09d8a-9811-11e3-85f8-00000aab0f6b&acdnat=1392668671_4377a56b825cf586cc9bc236f3ad3f3c. Spanish.
Pascual I, Pascual SI. Neurofibromatosis type 1 (NF1) associated with tumor of the corpus callosum. Childs Nerv Syst [Internet]. 2012 Dec [cited 2014 Jan 6];28(12):2177–80. Available from: http://download.springer.com/static/pdf/165/art%253A10.1007%252Fs00381-012-1903-9.pdf?auth66=1393085479_1491348da5fabe525024ec5472568648&ext=.pdf
Pérez J. Apuntes sobre la historia de la Neurofibromatosis tipo I (enfermedad de Von Recklinghausen). Piel [Internet]. 2006 Jan [cited 2014 Jan 6];21(1):[about 5 p.]. Available from: http://www.elsevier.es/es/revistas/piel-21/apuntes-historia-neurofibromatosis-tipo-i-enfermedad-von-13083553-historia-2006. Spanish.
Sharif S, Upadhyaya M, Ferner R, Majounie E, Shenton A, Baser M, et al. A molecular analysis of individuals with neurofibromatosis type 1 (NF1) and optic pathway gliomas (OPGs), and an assessment of genotype–phenotype correlations. J Med Genet [Internet]. 2011 Apr [cited 2014 Jan 6];48(4):256–60. Available from: http://jmg.bmj.com/content/48/4/256.full.pdf+html
Fisher MJ, Loguidice M, Gutmann DH, Listernick R, Ferner RE, Ullrich NJ, et al. Visual outcomes in children with neurofibromatosis type 1–associated optic pathway glioma following chemotherapy: a multicenter retrospective analysis. Neuro Oncol [Internet]. 2012 Jun [cited 2014 Jan 6];14(6):[about 8 p.]. Available from: http://neuro-oncology.oxfordjournals.org/content/14/6/790.full.pdf+html
Vogt J, Kohlhase J, Morlot S, Kluwe L, Mautner VF, Cooper DV, et al. Monozygotic twins discordant for neurofibromatosis type 1 due to a postzygotic NF1 gene mutation. Hum Mutat [Internet]. 2011 Jun [cited 2014 Jan 6];32(6):E2134–47. Available from: http://onlinelibrary.wiley.com/doi/10.1002/humu.21476/pdf
Pascual I, Pascual SI, Velázquez R, Viaño J. Tumor del cuerpo calloso como presentación de neurofibromatosis tipo 1 en un paciente y revisión de la bibliografía. Rev Neurol [Internet]. 2012 Nov 1 [cited 2014 Jan 6];55(9):528–32. Available from: http://www.neurologia.com/pdf/Web/5509/bi090528.pdf. Spanish.